QIAGEN N.V. Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount
QIAGEN N.V. (QGEN) had Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount of $700.00 thousand as of 2022-12-31, per its 20-F filed 2023-03-13.
Discontinued › Notes › Investments › Debt and Equity Securities
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount · last filed 2023-03-13
- 2022-12-31: Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount $700.00K.
- 2021-12-31: Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount $700.00K.
- 2020-12-31: Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount $700.00K.
| Period end | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount |
|---|---|
| 2022-12-31 | $700.00K 20-F · filed 2023-03-13 |
| 2021-12-31 | $700.00K 20-F · filed 2023-03-13 |
| 2020-12-31 | $700.00K 20-F · filed 2021-03-05 |